Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 14/20 | 0.69 |
| ▸ | CPB1 | P15086 | 8/20 | 0.69 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.50 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.39 |
| ▸ | TPH1 | P17752 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8346107 | 0.86 | CPB2 (0.61) | CPB2CPB1KDM4CLNPEP | |
| SCHEMBL6248361 | 0.82 | CPB2 (0.74) | CPB2CPB1KDM4CLNPEP | |
| SCHEMBL8346104 | 0.82 | CPB2 (0.62) | CPB2CPB1KDM4CLNPEP | |
| SCHEMBL6493209 | 0.82 | CPB2 (1.00) | CPB2CPB1KDM4C | |
| Hydrochloric Acid SCHEMBL6484890 | 0.82 | CPB2 (0.73) | CPB2CPB1KDM4CLNPEP | |
| Hydrochloric Acid SCHEMBL6484886 | 0.82 | CPB2 (0.67) | CPB2CPB1KDM4CLNPEP | |
| Hydrochloric Acid SCHEMBL6485970 | 0.82 | CPB2 (0.67) | CPB2CPB1KDM4CLNPEP | |
| Hydrochloric Acid SCHEMBL6485972 | 0.82 | CPB2 (0.73) | CPB2CPB1KDM4CLNPEP | |
| SCHEMBL6493995 | 0.80 | CPB2 (0.71) | CPB2CPB1KDM4C | |
| SCHEMBL6917738 | 0.80 | CPB2 (0.71) | CPB2CPB1KDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6919457-B2 | 3-(imidazolyl)-2-aminopropanoic acids | PFIZER, INC. (US) | 2005-07-19 | — | — | US | disclosed |
| US-20040192668-A1 | 3-(imidazolyl)-2-aminopropanoic acids | PFIZER INC | 2004-09-30 | — | — | US | disclosed |
| US-6759426-B2 | RESPIRATORY SYSTREM DISORDERS; ANTIINFLAMMATORY AGENTS; RHEUMATIC DISORDERS | PFIZER INC | 2004-07-06 | — | — | US | disclosed |
| US-20030191107-A1 | 3-(Imidazolyl)-2-aminopropanoic acids | PFIZER INC. | 2003-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192668-A1 | 3-(imidazolyl)-2-aminopropanoic acids | FGB, F2, F11 | CPB2 733/4885CPB1 1085/4885KDM4C 3415/4885 |
| US-20030191107-A1 | 3-(Imidazolyl)-2-aminopropanoic acids | FGB, F2, F11 | CPB2 733/4885CPB1 1085/4885KDM4C 3415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.